Avadel Pharmaceuticals plc ADR buy Taurito
Zusammenfassung
Diese Einschätzung wurde am 15.10.22 mit einem Endkurs von 6,05 € beendet. Nahezu unverändert schloss die BUY Einschätzung zu Avadel Pharmaceuticals plc ADR. Diese Einschätzung von Taurito ist reine Spekulation, sie zählt nicht für die Renditestatistiken.Avadel Pharmaceuticals: A Brief Overview
Avadel Pharmaceuticals (Symbol: FLML, WKN A2DJR8) is a specialty pharmaceutical company publicly traded on the stock exchange, which focuses on the development, manufacturing, and commercialization of innovative pharmaceutical products. By utilizing their proprietary drug delivery technology platform, Avadel aims to improve the performance and patient experience of existing drugs, primarily within the areas of central nervous system (CNS) disorders and sleep medicine. Headquartered in Dublin, Ireland, this company combines both research and development expertise along with strong commercial capabilities to bring unique solutions for patients in need. One of their prominent products, FT218, is an investigational once-nightly sodium oxybate formulation for the treatment of narcolepsy - an example of their dedication to revolutionizing sleep medicine.
Rendite ohne Dividenden (%)
| Name | 1W | 1M | 1J |
|---|---|---|---|
| Avadel Pharmaceuticals plc ADR | - | - | - |
| iShares Core DAX® | -1,37 % | -3,23 % | 11,66 % |
| iShares Nasdaq 100 | 0,17 % | -3,34 % | 36,49 % |
| iShares Nikkei 225® | -0,80 % | -7,86 % | 18,60 % |
| iShares S&P 500 | -0,37 % | -2,98 % | 26,34 % |
Kommentare von Taurito zu dieser Einschätzung
In der Diskussion Avadel Pharmaceuticals plc ADR diskutieren
In der Diskussion Trading Avadel Pharmaceuticals plc ADR
Beendete Einschätzungen von Taurito zu Avadel Pharmaceuticals plc ADR
Avadel Pharmaceuticals plc ADR
18.06.22
18.06.23
26.06.22
Avadel Pharmaceuticals plc ADR
28.05.22
28.05.23
18.06.22